Sumary of India to review COVID-19 vaccines after blood clot warning – report:
- Article content A government panel of experts is investigating for any domestic cases of blood clotting, even mild ones, as a side effect of the two COVID-19 vaccines being administered in India, financial daily Mint reported on Friday, citing two people aware of the development..
- India is currently administering AstraZeneca COVID-19 vaccine, which is manufactured by the Serum Institute and branded Covishield, and a shot developed by Bharat Biotech called COVAXIN..
- The review comes after Europe drug regulator said on Wednesday it found a possible link between AstraZeneca vaccine and rare blood clotting issues in adults who had received the shot, although it added the vaccine advantages still outweighed the risks..
- “We are looking at side-effects of blood clots that have been seen in people who received Covishield and Covaxin, even if it was a mild case,”…